Oncolys in Talks with Checkpoint Drug Makers for Telomelysin: President

Oncolys BioPharma President Yasuo Urata Tokyo-based biotech Oncolys BioPharma is in talks with several major drug makers that have immune checkpoint inhibitors in their portfolios for the possible out-licensing of its oncolytic virus telomelysin, President Yasuo Urata revealed on February...read more